Project Grant HT94252310441
Award Date
6/1/23
Completion Date
5/31/27
Dollars Obligated
$1.7M
Federal Agency
Defense Health Agency
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
Yale University received a $1,618,571 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The award will fund research from June 2023 through May 2027 to investigate the role of immune cell-podocyte crosstalk in the pathogenesis of APOL1-FSGS and proteinuric kidney disease. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
Yale University was awarded an $11,577,868 project grant from the Defense Health Agency to research polycystic kidney disease under the Military Medical Research and Development program (CFDA 12.420). The grant period runs from September 1, 2021 through August 31, 2025. Through this funding, Yale researchers will investigate polycystic kidney disease as a disorder of glomerulotubular synchronization. The Military Medical Research and Development program aims to transform military and public...
This federal Project Grant award of $460,279.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Yale University. The award supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. Specifically, the grant will fund research on the "Loss of Proteostasis and Vascular Amyloidosis" to advance disease prevention, diagnosis, treatment, and management...
The Department of the Army Medical Command awarded Yale University a $1,004,997 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund Yale University's pilot development of new forms of chimeric antigen receptor therapies for kidney cancer from August 15, 2021 to August 14, 2024. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
The Department of the Army Medical Command awarded Yale University a $2,639,485 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from December 2021 through November 2025 to investigate inhibition of the IRE1alpha-XBP1 pathway using toyocamycin as a novel approach to inhibit progression of autosomal dominant polycystic kidney and liver disease. The Military Medical Research and Development program supports basic, applied, and...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
Yale University was awarded a $335,000 project grant from the Defense Health Agency through the Military Medical Research and Development program. The grant will support Yale University's "IMAGING METRIX REMODELING IN PULMONARY FIBROSIS" project from April 1, 2021 to September 30, 2023. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative biomedical research. Under this award, Yale University will...
This federal Project Grant award for $837,497.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The purpose of this award to Yale University is to conduct research on "Feeding Stress Primes the Pancreas for Cancer". The award period runs from November 1, 2024 to October 31, 2027 and aims to...
This federal Project Grant award, totaling $1,009,054.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports advanced biomedical research conducted by Yale University to investigate the discovery and therapeutic targeting of endogenous retroviruses in clear cell renal cell carcinoma. The research project aims to transform healthcare for military service members and the broader public by advancing...